He describes the Rusfertide result, which is partnered with Takeda and was presented in a plenary session at ASCO. Plus, he covers a UC announcement that JNJ made in March, and guides for when Protagonist will announce an obesity program.
View all episodes
By BiotechTV
4.3
66 ratings
He describes the Rusfertide result, which is partnered with Takeda and was presented in a plenary session at ASCO. Plus, he covers a UC announcement that JNJ made in March, and guides for when Protagonist will announce an obesity program.
3,223 Listeners
1,917 Listeners
124 Listeners
325 Listeners
61 Listeners
9,948 Listeners
86 Listeners
33 Listeners
353 Listeners
19 Listeners
60 Listeners
510 Listeners
41 Listeners
0 Listeners
4 Listeners
2 Listeners
6 Listeners
48 Listeners